Cherry is a Buy Now, Pay Later financing platform for medical and wellness services, available as a consumer mobile app on iOS and Android.
The App DNA
What makes this app unique?
It removes the financial barrier to elective medical care by providing instant, interest-free payment plans that do not impact the patient's credit score.
For Patients seeking financing for elective health and wellness procedures, and medical practices looking to increase case acceptance rates.
What does it look like?
Key features
Financing platform for medical and wellness services with terms from 1 to 60 months and amounts up to $65,000.
Automated credit decisioning for consumers with a reported 90% approval rate.
Application process that does not impact the consumer's credit score.
How much does it cost?
The consumer app is free to use, with revenue generated via B2B merchant fees charged to healthcare providers.
Velocity
Maintenance developmentUX improvementsperformanceShow more...
Cherry currently ships at a maintenance cadence, with only one version released in the observed window. Development focus is centered on security infrastructure and core utility improvements, specifically the transition to OAuth and the addition of direct bank account integration. The current release pattern suggests a focus on stability and essential feature parity rather than rapid iteration. Future updates are expected to follow this infrequent, utility-focused trajectory.
Who built it?
Cherry Technologies
4 apps tracked · Finance
User Sentiment
What do users think recently?
Fresh user feedback skews excited. Users appreciate the streamlined application process provides immediate financial relief for urgent veterinary and dental care needs and the mobile interface offers a clean and intuitive alternative to the previous web-only account management experience, but report authentication failures prevent users from logging in after the latest update due to unresponsive verification code inputs.
How are ratings & reviews evolving?
Weekly average review rating
What users say, by theme
- The streamlined application process provides immediate financial relief for urgent veterinary and dental care needs
- The mobile interface offers a clean and intuitive alternative to the previous web-only account management experience
- Interest-free payment options allow users to manage high-cost medical bills without incurring additional financial debt
- Authentication failures prevent users from logging in after the latest update due to unresponsive verification code inputs
64 of 64 recent reviews analyzed · high confidence · Excited overall
Read the full review analysisUnlock 2 more frustration themes, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Cherry: The Smarter Way to Pay
How's the Finance market?
Cherry maintains a strong rating of 4.49 on Android and 4.86 on iOS across 427 total ratings. The platform's focus on medical-specific financing creates a distinct barrier to entry compared to general-purpose BNPL providers.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Cherry: The Smarter Way to Pay
Where is it heading?
The medical financing market is consolidating around platforms that offer seamless integration with practice management software. Cherry's maintenance-level release cadence leaves it vulnerable to competitors that can iterate faster on user-reported billing and authentication friction.
- Authentication regressions in the latest release block user access, which directly increases support volume and erodes trust in the platform's reliability.
- Direct bank account linking in the latest release provides a mechanism to improve payment success rates and reduce manual billing discrepancies.
The SWOT
- Automated credit decisioning with 90% approval rate
- Interest-free financing options for elective medical care
- Soft-credit application process preserves consumer credit scores
- Direct bank account linking reduces payment failure rates
Next best moves
Rebuild verification code input field because the latest update prevents user login → restore account access
+ 1 more prioritized moveThe counter-intuitive read
The reliance on automated credit decisioning is a risk, not just a strength…
Read the full takeSince the last report: The outlook has shifted from stable to mixed as the platform faces increased scrutiny regarding its credit decisioning transparency and persistent authentication regressions. While the core financing utility remains unchanged, the risk profile has expanded to include regulatory concerns.
Bottom line
Cherry's value rests on the speed of its medical financing approval, but the current authentication regressions in the latest release are actively eroding the user trust required for financial services.
Unlock 3 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated